These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 3726071)
1. Scientific and ethical considerations in the use of placebo controls in clinical trials in psychopharmacology. Klerman GL Psychopharmacol Bull; 1986; 22(1):25-9. PubMed ID: 3726071 [No Abstract] [Full Text] [Related]
2. An integration of ethical and clinical considerations in the use of placebos. Stanley B Psychopharmacol Bull; 1988; 24(1):18-20. PubMed ID: 3387520 [No Abstract] [Full Text] [Related]
3. Control groups in psychosocial intervention research: ethical and methodological issues. Street LL; Luoma JB Ethics Behav; 2002; 12(1):1-30. PubMed ID: 12171079 [TBL] [Abstract][Full Text] [Related]
4. The interplay between scientific gain and ethical concerns in outcome research. Foa EB; Steketee GS Behav Assess; 1981; 3(3-4):255-64. PubMed ID: 11665268 [No Abstract] [Full Text] [Related]
5. Safety of patients participating in drug trials. Use of placebo in trials of drugs for mental illness should be debated. Armstrong E BMJ; 1998 Sep; 317(7161):818. PubMed ID: 9786685 [No Abstract] [Full Text] [Related]
6. Placebo controls are not good science. Weijer C; Appelbaum P IRB; 1996; 18(5):8-10. PubMed ID: 11654741 [No Abstract] [Full Text] [Related]
7. Debate about placebos points to issue surrounded by many shades of grey. Baer N CMAJ; 1996 Nov; 155(10):1475-6. PubMed ID: 8943938 [TBL] [Abstract][Full Text] [Related]
8. [Placebo-controlled trials in schizophrenia]. Melamed Y; Davidson M; Bleich A Harefuah; 2004 Mar; 143(3):236-40, 244. PubMed ID: 15065367 [TBL] [Abstract][Full Text] [Related]
9. Ethical, scientific, and regulatory perspectives regarding the use of placebos in cancer clinical trials. Daugherty CK; Ratain MJ; Emanuel EJ; Farrell AT; Schilsky RL J Clin Oncol; 2008 Mar; 26(8):1371-8. PubMed ID: 18227527 [TBL] [Abstract][Full Text] [Related]
10. Placebo controls: scientific and ethical issues. Kowalski CJ Am J Bioeth; 2002; 2(2):33-4. PubMed ID: 12189073 [No Abstract] [Full Text] [Related]
11. Dilemmas in the use of active control groups in clinical research. Makuch RW; Johnson MF IRB; 1989; 11(1):1-5. PubMed ID: 11659084 [No Abstract] [Full Text] [Related]
12. Ethical questions in human clinical psychopharmacology: should the focus be on placebo administration? Kotzalidis G; Pacchiarotti I; Manfredi G; Savoja V; Torrent C; Mazzarini L; Tatarelli C; Amann B; Di Marzo S; Sánchez-Moreno J; Sani G; Girardi P; Colom F; Vieta E J Psychopharmacol; 2008 Aug; 22(6):590-7. PubMed ID: 18515445 [TBL] [Abstract][Full Text] [Related]
13. Placebo: pro and con. Lapierre YD; Weijer C NCEHR Commun; 1997-1998 Winter-Spring; 8(2):11-5. PubMed ID: 11660612 [No Abstract] [Full Text] [Related]
14. [Ethics and clinical trials]. Abadie E Encephale; 1990; 16(4):275-6. PubMed ID: 2209481 [TBL] [Abstract][Full Text] [Related]
16. [Sensible use of placebo in psychopharmacological research]. Kotler M; Witztum E Harefuah; 1999 May; 136(9):692-4. PubMed ID: 10955091 [No Abstract] [Full Text] [Related]
17. [The placebo problem. Individual and socio-ethical considerations on controlled therapeutic trials]. Müller-Oerlinghausen B MMW Munch Med Wochenschr; 1983 Feb; 125(5):80-4. PubMed ID: 6405223 [No Abstract] [Full Text] [Related]
18. Ethics, methodology and the use of placebo controls in surgical trials. Polgar S; Ng J Brain Res Bull; 2005 Oct; 67(4):290-7. PubMed ID: 16182936 [TBL] [Abstract][Full Text] [Related]